Strategic Blueprint, LLC Invitae Corp Transaction History

Strategic Blueprint, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$0.0 - $0.01 $0 - $3	-300 Reduced 1.06%	28,016 $0
Q1 2024 Apr 23, 2024	SELL	$0.01 - $0.61 $2 - $131	-215 Reduced 0.75%	28,316 $0
Q3 2023 Oct 18, 2023	BUY	$0.6 - $1.53 $6,000 - $15,300	10,000 Added 53.96%	28,531 $17,000
Q1 2023 Apr 28, 2023	BUY	$1.2 - $2.73 $22,237 - $50,589	18,531 New	18,531 $25,000
Q3 2021 Nov 12, 2021	SELL	$24.31 - $33.6 $12,519 - $17,304	-515 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$26.09 - $40.4 $13,436 - $20,806	515 New	515 $17,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Strategic Blueprint, LLC, based on Form 13F filings with the SEC.

Stay updated on Strategic Blueprint, LLC with notifications on news.